The Effect of Kyphoplasty on Opioid Use in Patients With Vertebral Compression Fractures

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Mar 15

PMID 38487151

Authors

Ben Silverman

Frances Shofer

Kirk Bonner

Stephen Hampton

Affiliations

Soon will be listed here.

Abstract

Objective The primary objective of this study was to assess opioid use in the 90 days following kyphoplasty (KP) compared to the period between compression fracture and KP. Methods All patients aged 50-85 who underwent KP following a newly diagnosed vertebral compression fracture (VCF) at a large, urban academic medical center between January 1st, 2015, and January 1st, 2023, were screened for inclusion. Patients were excluded if they had an opioid prescription in the month prior to the compression fracture, had a history of malignancy, or underwent concomitant or other surgical procedures in the 90 days following KP. Opioid measures, including the prescribed amount of morphine milliequivalents (MME) per day, number of opioid days, and total MME (MME per day x number of opioid days), in addition to numerical rating scale (NRS) pain scores, were analyzed pre- and post-KP. Results A total of 27 patients met the eligibility criteria, with a mean age of 69.7 and 59.2% being female. Sixteen patients (59%) had received an opioid prescription between compression fracture and KP (opioid group). The median differences pre- and post-KP in prescribed MMEs per day, number of opioid days, and total MMEs were 17.7 (p=.0009), 11.0 (p=.0004), and 232.5 (p<.0001), respectively. There was a significant difference in NRS pain scores in both the opioid group (6.25, p<.0001) and the non-opioid group (4.36, p<.0001) pre- and post-KP. Conclusion Our findings suggest that KP may be associated with a reduction in both opioid use and pain scores in opioid-naïve patients with VCFs. Larger studies that directly compare KP to conservative management are needed to fully assess the impact of KP on opioid and pain outcome measures.

References

Dohm M, Black C, Dacre A, Tillman J, Fueredi G . A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. AJNR Am J Neuroradiol. 2014; 35(12):2227-36. PMC: 7965303. DOI: 10.3174/ajnr.A4127. View

Papanastassiou I, Phillips F, Van Meirhaeghe J, Berenson J, Andersson G, Chung G . Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies. Eur Spine J. 2012; 21(9):1826-43. PMC: 3459114. DOI: 10.1007/s00586-012-2314-z. View

Cherasse A, Muller G, Ornetti P, Piroth C, Tavernier C, Maillefert J . Tolerability of opioids in patients with acute pain due to nonmalignant musculoskeletal disease. A hospital-based observational study. Joint Bone Spine. 2004; 71(6):572-6. DOI: 10.1016/j.jbspin.2003.10.014. View

Compston J, McClung M, Leslie W . Osteoporosis. Lancet. 2019; 393(10169):364-376. DOI: 10.1016/S0140-6736(18)32112-3. View

Beall D, Chambers M, Thomas S, Amburgy J, Webb Jr J, Goodman B . Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial. Neurosurgery. 2018; 84(1):169-178. PMC: 6354561. DOI: 10.1093/neuros/nyy017. View

Manchikanti L, Abdi S, Atluri S, Balog C, Benyamin R, Boswell M . American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. Pain Physician. 2012; 15(3 Suppl):S67-116. View

Black D, Cummings S, Karpf D, Cauley J, Thompson D, Nevitt M . Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996; 348(9041):1535-41. DOI: 10.1016/s0140-6736(96)07088-2. View

Wardlaw D, Cummings S, Van Meirhaeghe J, Bastian L, Tillman J, Ranstam J . Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009; 373(9668):1016-24. DOI: 10.1016/S0140-6736(09)60010-6. View

Truumees E, Hilibrand A, Vaccaro A . Percutaneous vertebral augmentation. Spine J. 2004; 4(2):218-29. DOI: 10.1016/j.spinee.2003.08.029. View

10.

Edidin A, Ong K, Lau E, Kurtz S . Morbidity and Mortality After Vertebral Fractures: Comparison of Vertebral Augmentation and Nonoperative Management in the Medicare Population. Spine (Phila Pa 1976). 2015; 40(15):1228-41. DOI: 10.1097/BRS.0000000000000992. View

11.

Kim J, Kim J, Yee J, Song S, Gwak H . Risk factors of opioid-induced adverse reactions in elderly male outpatients of Korea Veterans Hospital. BMC Geriatr. 2018; 18(1):293. PMC: 6264622. DOI: 10.1186/s12877-018-0990-1. View

12.

Boonen S, Van Meirhaeghe J, Bastian L, Cummings S, Ranstam J, Tillman J . Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011; 26(7):1627-37. DOI: 10.1002/jbmr.364. View

13.

Chandra R, Maingard J, Asadi H, Slater L, Mazwi T, Marcia S . Vertebroplasty and Kyphoplasty for Osteoporotic Vertebral Fractures: What Are the Latest Data?. AJNR Am J Neuroradiol. 2017; 39(5):798-806. PMC: 7410658. DOI: 10.3174/ajnr.A5458. View

14.

Wong C, McGirt M . Vertebral compression fractures: a review of current management and multimodal therapy. J Multidiscip Healthc. 2013; 6:205-14. PMC: 3693826. DOI: 10.2147/JMDH.S31659. View

15.

Kutsal F, Ergin Ergani G . Vertebral compression fractures: Still an unpredictable aspect of osteoporosis. Turk J Med Sci. 2020; 51(2):393-399. PMC: 8203169. DOI: 10.3906/sag-2005-315. View

16.

McCullough B, Comstock B, Deyo R, Kreuter W, Jarvik J . Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Intern Med. 2013; 173(16):1514-21. PMC: 4023124. DOI: 10.1001/jamainternmed.2013.8725. View

17.

Rao R, Singrakhia M . Painful osteoporotic vertebral fracture. Pathogenesis, evaluation, and roles of vertebroplasty and kyphoplasty in its management. J Bone Joint Surg Am. 2003; 85(10):2010-22. View

18.

Jensen M, McGraw J, Cardella J, Hirsch J . Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological.... J Vasc Interv Radiol. 2007; 18(3):325-30. DOI: 10.1016/j.jvir.2007.01.014. View

19.

Kasper D . Kyphoplasty. Semin Intervent Radiol. 2011; 27(2):172-84. PMC: 3036523. DOI: 10.1055/s-0030-1253515. View

20.

Alexandru D, So W . Evaluation and management of vertebral compression fractures. Perm J. 2012; 16(4):46-51. PMC: 3523935. DOI: 10.7812/TPP/12-037. View